The delayed exposure to EE reversed functional damage and achieved a complete protection of RPE melanin content and RPE65-immunoreactivity and protein levels, thus being capable of actively supressing ongoing NE-AMD damage. The gene discussed is RPE65; the disease is age-related macular degeneration.